[go: up one dir, main page]

NO20030316L - Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker - Google Patents

Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker

Info

Publication number
NO20030316L
NO20030316L NO20030316A NO20030316A NO20030316L NO 20030316 L NO20030316 L NO 20030316L NO 20030316 A NO20030316 A NO 20030316A NO 20030316 A NO20030316 A NO 20030316A NO 20030316 L NO20030316 L NO 20030316L
Authority
NO
Norway
Prior art keywords
composition
humans
mixture
effect
infection
Prior art date
Application number
NO20030316A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030316D0 (no
Inventor
Florence Rochat
Olivier Ballevre
Alfred Jann
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20030316D0 publication Critical patent/NO20030316D0/no
Publication of NO20030316L publication Critical patent/NO20030316L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Grain Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
NO20030316A 2000-07-24 2003-01-21 Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker NO20030316L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00115850A EP1175905A1 (fr) 2000-07-24 2000-07-24 Composition nutritive
PCT/EP2001/008283 WO2002007533A2 (fr) 2000-07-24 2001-07-17 Composition nutritionnelle

Publications (2)

Publication Number Publication Date
NO20030316D0 NO20030316D0 (no) 2003-01-21
NO20030316L true NO20030316L (no) 2003-03-14

Family

ID=8169332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030316A NO20030316L (no) 2000-07-24 2003-01-21 Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker

Country Status (22)

Country Link
US (2) US20030166610A1 (fr)
EP (4) EP1175905A1 (fr)
JP (1) JP4955896B2 (fr)
KR (1) KR20030041962A (fr)
CN (1) CN100349575C (fr)
AT (1) ATE485827T1 (fr)
AU (1) AU2001289680A1 (fr)
BG (1) BG107473A (fr)
BR (2) BRPI0112685B1 (fr)
CA (1) CA2416990C (fr)
CZ (1) CZ2003535A3 (fr)
DE (1) DE60143356D1 (fr)
DK (1) DK1305036T3 (fr)
ES (2) ES2650122T3 (fr)
HU (1) HUP0303728A3 (fr)
IL (1) IL153989A (fr)
MX (1) MXPA03000742A (fr)
NO (1) NO20030316L (fr)
PL (1) PL366049A1 (fr)
PT (1) PT1305036E (fr)
WO (1) WO2002007533A2 (fr)
ZA (1) ZA200301401B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2815824B1 (fr) * 2000-10-31 2003-04-25 Colloides Naturels Internat Methode et preparation de type fibre alimentaire soluble bifidogene pour la mise en oeuvre de ladite methode
US8623402B2 (en) 2001-08-20 2014-01-07 Cargill, Incorporated Non-starch-polysaccharides
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
FR2848783B1 (fr) * 2002-12-18 2005-05-13 Agronomique Inst Nat Rech Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant
DK2368553T3 (en) 2003-04-08 2015-02-09 Progenics Pharm Inc Pharmaceutical preparation comprising methylnaltrexone
PT1675481E (pt) * 2003-10-24 2009-01-02 Nutricia Nv Composição sinbiótica para bebés
WO2005056022A1 (fr) * 2003-12-12 2005-06-23 Taiyo Kagaku Co., Ltd. Composition ameliorant l'enteropathie
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (fr) 2004-07-22 2006-02-02 Ritter Andrew J Procedes et compositions pour le traitement de l'intolerance au lactose
CN101128129A (zh) * 2005-02-28 2008-02-20 纽崔西亚公司 具有益生菌的营养组合物
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662390B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
ES2493590T3 (es) 2007-03-29 2014-09-12 Wyeth Llc Antagonistas de receptores opioides periféricos y usos de los mismos
EP3263571B2 (fr) 2007-03-29 2023-08-23 Progenics Pharmaceuticals, Inc. Forme cristalline de bromure de (r)-n-methylnaltrexone et utilisations associées
EP2137191B8 (fr) 2007-03-29 2016-06-08 Progenics Pharmaceuticals, Inc. Antagonistes de récepteurs opioïdes périphériques, et leurs utilisations
GB0718974D0 (en) 2007-09-28 2007-11-07 Univ Leuven Kath oligosaccharides derived from arabinoxylan for prevention of gastrointestinal infection
EP2589302B1 (fr) * 2007-12-21 2016-11-23 N.V. Nutricia Utilisation de shingomyéline et de glucides non digestibles pour améliorer le microbiote intestinal
EP2730578A1 (fr) 2008-02-06 2014-05-14 Progenics Pharmaceuticals, Inc. Préparation et utilisation de (r),(r)-2,2'-bis-methylnal trexone
JP5647098B2 (ja) 2008-03-21 2014-12-24 ザ ユニヴァーシティー オヴ シカゴ オピオイド拮抗薬とｍＴＯＲ阻害薬を用いた治療
GB0805360D0 (en) 2008-03-25 2008-04-30 Univ Leuven Kath Arabinoxylan oligosaccharide preparation
MX337272B (es) 2008-03-28 2015-10-06 Nestec Sa Probioticos para usarse en mamiferos hembra preñadas para incrementar la inmunidad de sus crias.
WO2010008272A1 (fr) * 2008-07-15 2010-01-21 N.V. Nutricia Traitement de troubles du transit intestinal
CA2676881C (fr) 2008-09-30 2017-04-25 Wyeth Antagonistes de recepteurs opioides peripheriques, et leurs utilisations
ES2600960T3 (es) 2009-02-24 2017-02-13 Ritter Pharmaceuticals, Inc. Formulaciones prebióticas y procedimientos de uso
MX336032B (es) 2009-11-12 2016-01-07 Nestec Sa Composicion nutricional para promover el balance y salud de la microbiota intestinal.
WO2011137249A1 (fr) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Formulations prébiotiques et méthodes d'utilisation
KR101421807B1 (ko) * 2012-09-28 2014-07-22 주식회사 포스코 코크스 오븐의 타르 제거장치
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
CN103704472B (zh) * 2013-12-13 2016-03-23 山东星光生物科技有限公司 一种低聚果糖功能性浓缩饲料及其制备方法
EP3082474A1 (fr) 2013-12-20 2016-10-26 Nestec S.A. Compositions nutritionnelles pour la réduction d'agents pathogènes intestinaux
CN104920809B (zh) * 2014-03-18 2018-02-23 中国科学院大连化学物理研究所 一种改善母猪奶水中乳汁寡糖的饲料添加剂预混剂及其使用方法
WO2015162447A1 (fr) * 2014-04-25 2015-10-29 Nexira International Utilisation d'une composition comprenant de la gomme arabique (ga) permettant d'améliorer l'imperméabilité intestinale
CN107106581B (zh) * 2014-10-03 2021-01-08 株式会社明治 低聚糖制剂和其制造方法
CN104939082A (zh) * 2015-06-02 2015-09-30 西安膳方医药科技有限公司 一种复合益生元及其制备方法
EP3331537B1 (fr) * 2015-08-04 2019-10-09 Südzucker AG Utilisation prophylactique d'inuline contre la sinusite
CA2995347A1 (fr) * 2015-08-11 2017-02-16 Shaklee Corporation Matieres et procedes d'amelioration de la sante gastro-intestinale
US20180200285A1 (en) * 2017-01-13 2018-07-19 Access Business Group International Llc Dietary prebiotic supplement and related method
CN108902970A (zh) * 2018-06-27 2018-11-30 安徽瑞康食品生物科技有限公司 含有戊聚糖的食用组合物，功能食品及其制备方法、用途
CN109315728A (zh) * 2018-09-19 2019-02-12 北京爱仁医疗科技有限公司 一种含有虾青素的食品及其在肠道菌群调节中的应用
WO2022083858A1 (fr) * 2020-10-21 2022-04-28 Compagnie Gervais Danone Gomme d'acacia pour une dysbiose microbienne induite par le fer
JP2024538978A (ja) * 2021-10-22 2024-10-28 マース インコーポレーテッド 食品組成物として使用するためのヌクレオチド及びオリゴ糖
JP7513327B1 (ja) 2023-09-01 2024-07-09 株式会社feileB 固形製剤
EP4559326A1 (fr) * 2023-11-23 2025-05-28 Rudjer Boskovic Institute Composition nutritionnelle comprenant de la curcumine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
CA2198681C (fr) * 1996-03-01 2004-10-26 Sherianne James Methode de preparation de sauces onctueuses sans gras ou faibles en gras au moyen de l'inuline
US5952033A (en) * 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP4273277B2 (ja) * 1999-06-30 2009-06-03 大塚製薬株式会社 オリゴ糖補給組成物

Also Published As

Publication number Publication date
EP1305036B1 (fr) 2010-10-27
IL153989A0 (en) 2003-07-31
JP2004504332A (ja) 2004-02-12
EP1175905A1 (fr) 2002-01-30
HUP0303728A3 (en) 2004-12-28
CN1466459A (zh) 2004-01-07
EP2204176A2 (fr) 2010-07-07
EP2204176A3 (fr) 2010-07-14
US20030166610A1 (en) 2003-09-04
WO2002007533A3 (fr) 2002-04-11
US7141554B2 (en) 2006-11-28
KR20030041962A (ko) 2003-05-27
PL366049A1 (en) 2005-01-24
WO2002007533A2 (fr) 2002-01-31
US20050053641A1 (en) 2005-03-10
ES2650122T3 (es) 2018-01-17
CN100349575C (zh) 2007-11-21
MXPA03000742A (es) 2003-09-25
EP1305036A2 (fr) 2003-05-02
NO20030316D0 (no) 2003-01-21
DE60143356D1 (de) 2010-12-09
CA2416990C (fr) 2010-09-14
HUP0303728A2 (hu) 2004-03-29
EP2255815A3 (fr) 2012-07-11
AU2001289680A1 (en) 2002-02-05
BR0112685A (pt) 2003-06-24
EP2255815B1 (fr) 2017-10-25
ATE485827T1 (de) 2010-11-15
BRPI0112685B1 (pt) 2020-04-07
ES2355754T3 (es) 2011-03-30
PT1305036E (pt) 2011-01-28
CA2416990A1 (fr) 2002-01-31
ZA200301401B (en) 2004-05-21
CZ2003535A3 (cs) 2003-09-17
JP4955896B2 (ja) 2012-06-20
DK1305036T3 (da) 2011-02-07
BG107473A (bg) 2004-07-30
IL153989A (en) 2005-08-31
EP2255815A2 (fr) 2010-12-01

Similar Documents

Publication Publication Date Title
NO20030316D0 (no) Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
PT1395269E (pt) Ácido lipoteicóico de bactérias ácido-lácticas para utilização como medicamento e no tratamento de doenças bacterianas
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
EA200300862A1 (ru) Связывание эндотоксина под действием лактобактерий и бифидобактерий
MXPA04005583A (es) Composicion para la promocion del crecimiento oseo y mantenimiento de la salud osea.
DE69636228D1 (de) Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
ATE228001T1 (de) Pharmazeutische zusammensetzungen für medizinische und veterinäre verwendung zur verbesserung der darmflora bei dyspeptischem syndrom und diarrhoeen auf dem veterinärsektor
PT1181047E (pt) Composicao compreendendo esfingomielinase alcalina para utilizacao como preparacao distetica suplemento alimentar ou produto farmaceutico
CN103908423B (zh) 抗口腔幽门螺杆菌中药牙膏
EP1393738A4 (fr) Traitement antidiabetique
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
GB2377638B (en) Treatment of infection in animals
Meheus Non-venereal treponematoses
Lessard Discussion: nutritional aspects of oral health--new perspectives
Nividita Puri Holistic approach of oil pulling in the dental world A literature review
PL374841A1 (en) Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
KR20040038401A (ko) 구내 종양 예방 및 조직 재생 분말
RU94024117A (ru) Способ лечения гастроэнтероколита
JPH03112935A (ja) 溶血性連鎖球菌に対する生体内殺菌剤
CN1057172A (zh) 有指袜